ORGS
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2024 Q3 | -0.19 | $347,000 | -$5M |
| 2024 Q2 | -0.23 | $246,000 | -$6M |
| 2024 Q1 | -0.29 | $141,000 | -$5M |
| 2023 Q4 | -2.09 | -$14M | -$557,000 |
| 2023 Q3 | 0.43 | $110,000 | -$1M |
| 2023 Q2 | -0.15 | $113,000 | -$6M |
| 2023 Q1 | -0.16 | $142,000 | -$9M |
| 2022 Q4 | -0.05 | $14M | -$16M |